News archive

Home News archivePage 2

Oncology: GSK Acquires U.S. Biotech IDRx

January 18, 2025 By Editorial Staff In Technologies
The British pharmaceutical giant GSK has announced the acquisition of the Boston-based biopharmaceutical company IDRx for $1.15 billion. This strategic acquisition is a key part of GSK’s broader plan to expand its portfolio through external investments. The deal will see GSK pay an upfront amount ...

ADIENNE Pharma & Biotech: A Success Story in Innovation

January 18, 2025 By Editorial Staff In Technologies
Antonio Francesco Di Naro
An Interview with Antonio Francesco Di Naro for the C Suite Feature of Sanità33, by Ludovico Baldessin From pioneering single-use technologies for manufacturing biological drugs to achieving a global patent leadership in preparing cytotoxic drugs by lyophilizing them directly in ready-to-use multi-...

ReChb: An Ancestral CRISPR–Cas12a variant with flexible applications

January 18, 2025 By Editorial Staff In R&D
Ancestral sequence reconstruction has led to the discovery and synthesis of ReChb, a revolutionary variant of CRISPR–Cas12a with remarkable versatility. ReChb’s ability to target any nucleic acid with minimal constraints positions it as a transformative tool for genome editing and genetic diagno...

Gut Revolution: Fecal Transplants vs. Live Biotherapeutic Products

January 18, 2025 By Editorial Staff In R&D
An article published in Gut Microbes (2024) introduces a groundbreaking class of drugs known as Live Biotherapeutic Products (LBPs), which are making waves in the biotechnology world. These “super bugs” are based on live microorganisms—such as bacteria, viruses, and fungi—engineered ...